NIM
VKTX icon

NEOS Investment Management’s Viking Therapeutics VKTX Stock Holding History

NEOS Investment Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,047
Closed -$494K – 658
2025
Q4 		$494K Buy
+14,047
New +$498K ﹤0.01% 609
2025
Q3 		– Sell
-19,755
Closed -$524K – 650
2025
Q2 		$524K Buy
19,755
+524
+3% +$13.8K 0.01% 541
2025
Q1 		$464K Sell
19,231
-984
-5% -$31.1K 0.01% 520
2024
Q4 		$813K Buy
20,215
+1,707
+9% +$97.3K 0.02% 448
2024
Q3 		$1.17M Buy
18,508
+1,425
+8% +$83.6K 0.04% 345
2024
Q2 		$906K Buy
17,083
+2,271
+15% +$149K 0.04% 345
2024
Q1 		$1.21M Buy
14,812
+241
+2% +$10.7K 0.08% 227
2023
Q4 		$271K Buy
+14,571
New +$191K 0.03% 419

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

NEOS Investment Management's VKTX Position: Q1 2026 in Review

NEOS Investment Management sold out of Viking Therapeutics (VKTX) in Q1 2026, closing a stake of 14,047 shares — an estimated $494K sold.

NEOS Investment Management first reported a position in VKTX in Q4 2023 and held it in 8 quarters. The position peaked at $1.21M in Q1 2024. 413 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • NEOS Investment Management reported no remaining Viking Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 14,047 Viking Therapeutics shares in Q1 2026, an estimated $494K.
  • NEOS Investment Management first reported a position in Viking Therapeutics in Q4 2023 and held it in 8 quarters.
  • NEOS Investment Management's Viking Therapeutics position peaked at $1.21M in Q1 2024.
  • 413 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.